December 10, 2025

The HIV Metric That Vanished

A CDC researcher recounts how key HIV data was ordered removed—and why he chose to walk away.

KFF Health News

December 05, 2025

On the Edge of a Measles Comeback?

New analysis examines rising U.S. measles outbreaks, associated clinical risks, and the potential loss of measles-elimination status.

KFF Health News

December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 04, 2025

FDA Approves Biologic for Nerve Repair

A newly licensed biologic offers a novel approach to repairing complex peripheral nerve injuries across pediatric and adult populations.

Conexiant

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

December 03, 2025

Are New Incentives Boosting Births?

A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.

KFF Health News

December 02, 2025

FDA Clears Rapid Bordetella PCR Test

The assay detects and differentiates key Bordetella species at the point of care, providing rapid results that support timely pertussis evaluation.

Conexiant

December 02, 2025

‘Liver Cancer Has Disappeared in Children’: But for How Long?

A review of the hepatitis B birth-dose recommendation examines vaccination practices, transmission risks, and potential impacts on newborn protection.

KFF Health News

November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant